{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:39:00Z","timestamp":1792571940881,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":225,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Molluscum contagiosum virus (MCV) is a human-specific poxvirus responsible for a common contagious skin infection, yet no licensed prophylactic vaccine is available. Therefore, this study aimed to identify potential vaccine candidates against MCV using integrated reverse vaccinology and immunoinformatics approach. Candidate proteins involved in immune evasion, viral entry, and virion assembly were assessed for physicochemical properties, transmembrane topology, antigenicity, allergenicity, and toxicity. Linear B-cell, cytotoxic T-lymphocyte (CTL), and helper T-lymphocyte (HTL) epitopes were predicted and prioritized based on antigenicity, safety, HLA-binding affinity, and worldwide population coverage. The selected epitopes were assembled into a multi-epitope vaccine construct, followed by physicochemical characterization, secondary and tertiary structure prediction, and molecular docking analysis with Toll-like receptor 4 (TLR4). Eight candidate proteins were selected for immunoinformatics analysis, of which six were predicted to be antigenic. Five HTL epitopes, five CTL epitopes, and three non-toxic antigenic B-cell epitopes were selected, providing an estimated worldwide population coverage of 80.69%. The final 351-amino acid construct had a predicted molecular weight of 37.48\u2009kDa, an instability index of 33.29, and a hydrophilic GRAVY value of \u22120.201. AlphaFold 3 produced a structurally organized model, while docking predicted a favorable interaction with TLR4 (score, \u2212190.46) supported by hydrogen bonds, salt bridges, and electrostatic interactions. The vaccine construct exhibited favorable physicochemical properties, broad population coverage, structural stability, and strong interaction with TLR4, suggesting its potential as a prophylactic vaccine candidate. Nevertheless, further in vitro and in vivo experimental validation is required to confirm its safety and protective efficacy.<\/jats:p>","DOI":"10.1093\/biomethods\/bpag045","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:46:56Z","timestamp":1786686416000},"source":"Crossref","is-referenced-by-count":0,"title":["Reverse vaccinology and immunoinformatics identify multi-epitope vaccine candidates against molluscum contagiosum virus"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8062-7472","authenticated-orcid":false,"given":"Shahrazad A","family":"Khalaf","sequence":"first","affiliation":[{"name":"Department of Forensic Sciences, College of Science, University of Diyala , Baqubah 32001, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaab M","family":"Jasim","sequence":"additional","affiliation":[{"name":"Department of Forensic Sciences, College of Science, University of Diyala , Baqubah 32001, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younus","family":"Jasim","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Technologies and Artificial Intelligence, High Institute of Health Technologies and Artificial Intelligence, Northern Technical University, Mosul 41000, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtada","family":"Naser","sequence":"additional","affiliation":[{"name":"Division of BioInvasions, Global Change and Macroecology, Department of Botany and Biodiversity Research, University of Vienna, Vienna 1030, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2026102103485927500_bpag045-B1","author":"Hebert AA, Bhatia N, Del Rosso JQ"},{"key":"2026102103485927500_bpag045-B2","doi-asserted-by":"publisher","author":"Ulrych JM, Krupa J, Malinowski M","journal-title":"Wiad Lek.","DOI":"10.36740\/WLek\/206905"},{"key":"2026102103485927500_bpag045-B3","author":"Bhatia N, Hebert AA, Del Rosso JQ","year":"2023","journal-title":"J Clin Aesthet Dermatol"},{"key":"2026102103485927500_bpag045-B4","article-title":". In: StatPearls [Internet].","author":"Badri","year":"2023"},{"key":"2026102103485927500_bpag045-B5","doi-asserted-by":"publisher","author":"Wang OJE, Shergill M, Saed Aldien A, Mukovozov I.","journal-title":"J Dtsch Dermatol Ges","DOI":"10.1111\/ddg.70100"},{"key":"2026102103485927500_bpag045-B6","doi-asserted-by":"publisher","author":"Li T, Gao N, Zeng Z, Fu G.","journal-title":"Front Pediatr","DOI":"10.3389\/fped.2025.1543309"},{"key":"2026102103485927500_bpag045-B7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/bs.aivir.2015.03.001","article-title":"Immune evasion strategies of molluscum contagiosum virus","volume":"92","author":"Shisler","year":"2015","journal-title":"Adv Virus Res"},{"key":"2026102103485927500_bpag045-B8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.36849\/JDD.7230","article-title":"Molluscum contagiosum virus evasion of immune surveillance: a review","volume":"22","author":"Han","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"2026102103485927500_bpag045-B9","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15063","author":"Chao YC, Ko MJ, Tsai WC, Hsu LY, Wu HY.","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026102103485927500_bpag045-B10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaad.2023.09.066","article-title":"Berdazimer gel for molluscum contagiosum: integrated analysis of phase 3 trials","volume":"90","author":"Sugarman","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2026102103485927500_bpag045-B11","author":"Al-Dojaily Y, Feldman SR.","year":"2025","journal-title":"J Clin Aesthet Dermatol"},{"key":"2026102103485927500_bpag045-B12","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1794832","volume-title":"Expert Rev Vaccines","author":"Kardani K, Bolhassani A, Namvar A.","year":"2020"},{"key":"2026102103485927500_bpag045-B13","doi-asserted-by":"publisher","author":"Mortazavi B, Molaei A, Allahyari Fard N","journal-title":"Hum Immunol","DOI":"10.1016\/j.humimm.2024.110804"},{"key":"2026102103485927500_bpag045-B14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"The Proteomics Protocols Handbook","author":"Gasteiger","year":"2005"},{"key":"2026102103485927500_bpag045-B15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J Exp Med"},{"key":"2026102103485927500_bpag045-B16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fmicb.2015.00123","article-title":"Pan-genome reverse vaccinology approach for the design of vaccines against pathogenic bacteria","volume":"6","author":"Naz","year":"2015","journal-title":"Front Microbiol"},{"key":"2026102103485927500_bpag045-B17","doi-asserted-by":"publisher","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation","volume":"44","author":"O\u2019Leary","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026102103485927500_bpag045-B18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41587-022-01554-9","article-title":"DeepTMHMM predicts alpha and beta transmembrane proteins using protein language models","volume":"40","author":"Hallgren","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2026102103485927500_bpag045-B19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"2026102103485927500_bpag045-B20","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J Mol Model"},{"key":"2026102103485927500_bpag045-B21","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2026102103485927500_bpag045-B22","doi-asserted-by":"publisher","first-page":"bbac174","DOI":"10.1093\/bib\/bbac174","article-title":"ToxinPred2: an improved method for predicting toxic peptides","volume":"23","author":"Sharma","year":"2022","journal-title":"Brief Bioinformatics"},{"key":"2026102103485927500_bpag045-B23","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by integrating mass spectrometry data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Research"},{"key":"2026102103485927500_bpag045-B24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"2026102103485927500_bpag045-B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"2026102103485927500_bpag045-B26","first-page":"53","article-title":"Immunoinformatics approaches to design multi-epitope vaccines","volume":"2131","author":"Pandey","year":"2018","journal-title":"Methods Mol Biol"},{"key":"2026102103485927500_bpag045-B27","doi-asserted-by":"publisher","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED protein analysis workbench: 20 years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026102103485927500_bpag045-B28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"2026102103485927500_bpag045-B29","doi-asserted-by":"publisher","first-page":"e00545-17","DOI":"10.1128\/JVI.00545-17","article-title":"Molluscum contagiosum virus protein MC005 inhibits NF-\u03baB activation by targeting NEMO-regulated I\u03baB kinase activation","volume":"91","author":"Brady","year":"2017","journal-title":"J Virol"},{"key":"2026102103485927500_bpag045-B30","doi-asserted-by":"publisher","first-page":"e00108-23","DOI":"10.1128\/jvi.00108-23","article-title":"Molluscum contagiosum virus protein MC008 targets NF-\u03baB activation by inhibiting ubiquitination of NEMO","volume":"97","author":"Phelan","year":"2023","journal-title":"J Virol"},{"key":"2026102103485927500_bpag045-B31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane fusion during poxvirus entry","volume":"60","author":"Moss","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"2026102103485927500_bpag045-B32","first-page":"2","volume-title":"Mechanisms of Viral Entry and Fusion: Developing Effective Inhibitors","author":"Bolarinwa","year":"2023"},{"key":"2026102103485927500_bpag045-B33","volume-title":"MC114R Protein, Molluscum contagiosum virus subtype 1 (UniProtKB accession: Q98281)","author":"UniProt Consortium","year":"2025"},{"key":"2026102103485927500_bpag045-B34","first-page":"2895","author":"H\u00fcttmann J, Krause E, Schommartz T, Brune W.","journal-title":"J Virol"},{"key":"2026102103485927500_bpag045-B35","doi-asserted-by":"publisher","first-page":"104876","DOI":"10.1016\/j.yexmp.2023.104876","article-title":"The MC160 protein of the molluscum contagiosum virus dampens cGAS\/STING-induced interferon-\u03b2 activation","volume":"134","author":"Reiss","year":"2023","journal-title":"Exp Mol Pathol"},{"key":"2026102103485927500_bpag045-B36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.virol.2017.02.017","article-title":"The molluscum contagiosum virus protein MC163 localizes to the mitochondria and dampens mitochondrial-mediated apoptotic responses","volume":"505","author":"Coutu","year":"2017","journal-title":"Virology"},{"key":"2026102103485927500_bpag045-B37","doi-asserted-by":"publisher","first-page":"8777","DOI":"10.1128\/JVI.75.19.8777-8784.2001","article-title":"The MC159 protein of molluscum contagiosum virus inhibits apoptosis and NF-\u03baB activation","volume":"75","author":"Nichols","year":"2001","journal-title":"J Virol"},{"key":"2026102103485927500_bpag045-B38","volume-title":"Fields Virology","author":"Moss","year":"2013"},{"key":"2026102103485927500_bpag045-B39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41577-019-0130-3","article-title":"A brief history of T cell help to B cells","volume":"19","author":"Crotty","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2026102103485927500_bpag045-B40","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"key":"2026102103485927500_bpag045-B41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Crystallogr"},{"key":"2026102103485927500_bpag045-B42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","article-title":"VERIFY3D: assessment of protein models with three-dimensional profiles","volume":"277","author":"Eisenberg","year":"1997","journal-title":"Methods Enzymol"},{"key":"2026102103485927500_bpag045-B43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"2026102103485927500_bpag045-B44","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat Protoc"},{"key":"2026102103485927500_bpag045-B45","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2026102103485927500_bpag045-B46","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1007\/s00253-022-11988-x","article-title":"A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus","volume":"106","author":"Kibria","year":"2022","journal-title":"Appl Microbiol Biotechnol"},{"key":"2026102103485927500_bpag045-B47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/vaccines12040392","article-title":"Immunoinformatics design and in vivo immunogenicity evaluation of a conserved CTL multi-epitope vaccine targeting HPV16 E5, E6, and E7 proteins","volume":"12","author":"Guo","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026102103485927500_bpag045-B48","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/ph17111498","article-title":"Design, development and immunogenicity study of a multi-epitope vaccine prototype against SARS-CoV-2","volume":"17","author":"Atanasova","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026102103485927500_bpag045-B49","author":"Leal LR, De Sena MG, Inven\u00e7\u00e3o MD","journal-title":"Vaccines"}],"container-title":["Biology Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomethods\/advance-article-pdf\/doi\/10.1093\/biomethods\/bpag045\/70648276\/bpag045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag045\/70648276\/bpag045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag045\/70648276\/bpag045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:49:04Z","timestamp":1792568944000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomethods\/article\/doi\/10.1093\/biomethods\/bpag045\/8761376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/biomethods\/bpag045","relation":{},"ISSN":["2396-8923"],"issn-type":[{"value":"2396-8923","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"bpag045"}}